CA2075776A1 - Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofen - Google Patents
Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofenInfo
- Publication number
- CA2075776A1 CA2075776A1 CA002075776A CA2075776A CA2075776A1 CA 2075776 A1 CA2075776 A1 CA 2075776A1 CA 002075776 A CA002075776 A CA 002075776A CA 2075776 A CA2075776 A CA 2075776A CA 2075776 A1 CA2075776 A1 CA 2075776A1
- Authority
- CA
- Canada
- Prior art keywords
- radical
- formula
- phenyl
- ketoprofen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- DKYWVDODHFEZIM-NSHDSACASA-N dexketoprofen Chemical compound OC(=O)[C@@H](C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-NSHDSACASA-N 0.000 title claims abstract description 8
- 229960002783 dexketoprofen Drugs 0.000 title claims abstract description 8
- 239000000543 intermediate Substances 0.000 title 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 12
- 230000008569 process Effects 0.000 claims abstract description 12
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims abstract description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 10
- -1 benzyloxy, phenoxy Chemical group 0.000 claims abstract description 9
- 150000002148 esters Chemical class 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 4
- 125000001841 imino group Chemical group [H]N=* 0.000 claims abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 4
- 239000001301 oxygen Substances 0.000 claims abstract description 4
- 125000000000 cycloalkoxy group Chemical group 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 150000002561 ketenes Chemical class 0.000 claims description 5
- 150000003512 tertiary amines Chemical class 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 claims description 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 3
- 150000003254 radicals Chemical class 0.000 claims description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 5
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 abstract description 14
- DKYWVDODHFEZIM-LLVKDONJSA-N (2r)-2-(3-benzoylphenyl)propanoic acid Chemical compound OC(=O)[C@H](C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-LLVKDONJSA-N 0.000 abstract description 4
- 125000003545 alkoxy group Chemical group 0.000 abstract description 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 45
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 19
- 238000007792 addition Methods 0.000 description 17
- 239000000203 mixture Substances 0.000 description 14
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004817 gas chromatography Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 4
- 229940105325 3-dimethylaminopropylamine Drugs 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 4
- LZCLXQDLBQLTDK-BYPYZUCNSA-N ethyl (2S)-lactate Chemical compound CCOC(=O)[C@H](C)O LZCLXQDLBQLTDK-BYPYZUCNSA-N 0.000 description 4
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 4
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- WBPAQKQBUKYCJS-ZCFIWIBFSA-N 2-methylpropyl (2r)-2-hydroxypropanoate Chemical compound CC(C)COC(=O)[C@@H](C)O WBPAQKQBUKYCJS-ZCFIWIBFSA-N 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000001282 iso-butane Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- MFSJSVNVUDQHLV-MERQFXBCSA-N (2S)-2-(3-benzoylphenyl)propanoic acid 2-(3-benzoylphenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC(C(=O)C2=CC=CC=C2)=CC=C1.C(C1=CC=CC=C1)(=O)C=1C=C(C=CC1)[C@@H](C(=O)O)C MFSJSVNVUDQHLV-MERQFXBCSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- RYYYTOGKTKBJDJ-UHFFFAOYSA-N 2-(3-benzylphenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=CC(CC=2C=CC=CC=2)=C1 RYYYTOGKTKBJDJ-UHFFFAOYSA-N 0.000 description 1
- YEBLAXBYYVCOLT-UHFFFAOYSA-N 2-hydroxy-n,n-dimethylpropanamide Chemical compound CC(O)C(=O)N(C)C YEBLAXBYYVCOLT-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- NPXFBUMWVJCDPX-QKKBWIMNSA-N C(C1=CC=CC=C1)(=O)C=1C=C(C=CC1)[C@@H](C(=O)[C@@](C(=O)OCC)(O)C)C Chemical compound C(C1=CC=CC=C1)(=O)C=1C=C(C=CC1)[C@@H](C(=O)[C@@](C(=O)OCC)(O)C)C NPXFBUMWVJCDPX-QKKBWIMNSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- AYTHBBAKQYDEPO-UHFFFAOYSA-N ethylcyclohexane Chemical compound C[CH]C1CCCCC1 AYTHBBAKQYDEPO-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/12—Ketones containing more than one keto group
- C07C49/15—Ketones containing more than one keto group containing rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Abstract of the Disclosure The invention relates to novel diastereomerically pure esters of ketoprofen of the formula:
Ia Ib (S-ketoprofen) (R-ketoprofen) (wherein:
R1 is in which R2 is alkyl, cycloalkyl, benzyl or phenyl;
Y is alkoxy, cycloalkoxy, benzyloxy, phenoxy or amino substituted by alkyl, cycloalkyl, benzyl or phenyl, or R1 is a group -
Ia Ib (S-ketoprofen) (R-ketoprofen) (wherein:
R1 is in which R2 is alkyl, cycloalkyl, benzyl or phenyl;
Y is alkoxy, cycloalkoxy, benzyloxy, phenoxy or amino substituted by alkyl, cycloalkyl, benzyl or phenyl, or R1 is a group -
Description
2~7~';~.'{,`
The invention relateq to novel diastereomerically pure esters of ketoprofen, to processe~ for their preparation by asymmetric ketene addition ~nd to their use in the preparation of (R)- or (S)-ketoprofen.
Pharmacological properties of active ingredients very often depend on the ab~olute stereochemistry. This phenomenon has also been observed with nonsteroidal analgesics and antipyretics of the class of 2-aryl-propionic acids. For these reasons various methods for the preparation of enantiomerically pure carboxylic acids having a chiral ~-C atom have been developed.
The preparation of (S)- or (R)-ketoprofen by methods known to date gives only poor results. In the racemate separation of 2-(3-benzylphenyl)-propionic acid and also in the asymmetric hydrogenation of dehydroketoprofen using chiral rhodium catalysts, only poor yields are obtained, ju~t as i8 the case with oxidation to give (S)-ketoprofen (compare G. Comisso et al., Gazz. Chim.
Italia 110, 123 (1980)). Thi~ also applies to racemate separation of 2-(2-thiaxanthonyl)-propionic acids with subsequent multistage conversion to (S)-ketoprofen (compare US 3 641 127) and to direct racemate separation using phenethylamins (compare DE 3 824 353). Also, by chromatographic separation of the diastereomeric amides of ketoprofen with chiral amines, only small amounts of (S3-ketoprofen are obtainable following hydrolysis of the Le A 28 573 - 1 -Z~7;~776 amides (compare Abas et al., J. Pharmacol. Exp. Ther.
240, 637 ~1987)). Enzymatic e~tor hydroly~e~ also fail in the preparation of enantiomerically puro ketoprofon ~compare S.~. Wu ot al., J. Am. Chom. Soc., 112, 1990 (1990)).
In summary it can be ~aid that no suitable prep~ration processe~ are known to date for the industrial production of relatively large amounts of (S)- or (R)-ketoprofen.
It is further known to react activated racemic carboxylic acid derivatives with catalysis using chiral titanium complexes to give enantiomerically enriched esters (compare X. Narasaka et al., Chem. Lett. 1989, 1187).
These reactions have the advantage over classical racemate separation that they can in principle deliver yields greater than 50 %. US 4 691 020 and EP 390 273 further disclose additions of optically active alcohols ; and ~-hydroxyesters or ~-hydroxyamides ta certain ketenes, which lead to esters having diastereomeric ~; excesses.
' It is shown that the hitherto known and conventional methods for the separation of optical isomers of 2-aryl-propionic acids cannot be directly applied to ketoprofen.
`- Methods which can be used successfully, for example with the arylpropionic acid ibuprofen, fail when they are applied to ketoprofen or give only unsatisfactory yields.
In a comparison of the structures, those skilled in the art could infer that, in the ca~e of ketoprofen, Le A 28 573 - 2 -2 ~ S~7 ~
particularly difficult ~teric conditions are prosent.
It has surprisingly been fount that ~S)- and ~R)-keto-profen of the formulae Ia and Ib, respectively, ~ ~Y
o ~ OOH O
~ (St ~ ~ R) Ia Ib (S-ketoprofen) (R-ketoprofen) are obtained in a simple manner, in high purity and in good yields, if racemic ketoprofen of the formula Me COOH
~ (II) i9 reacted via the acid chloride in the preRence of tertiary amines to give ketenes of the general formula (III) : Me C=C=o ~ (III) Le A 28 573 - 3 -2~ 7fi this ketene is then transferred into a eeparate reaction vessel and i8 there reacted at temperatures between -100C and +25C with alcohols of the general formula (IV) Rl-OH (IV) in which IR~
Rl represents the -CH-CO-Y radical, where R~ represents a C~lO-alkyl radical, C3,-cycloalkyl 10radical, ben~yl or phenyl, and Y rapresents a C,10-alkoxy radical, a C3l0-cyclo-alkyloxy radical, benzyloxy or phenoxy, or Y represents an amine radical, which iB identi-cally or differently substituted by alkyl or cycloalkyl having up to 10 C atoms, benzyl or phenyl, or Rl represents a radical of the formula ~3 - x -CH - CO
Le A 28 573 - 4 -z ~7 Sq7 6 23189-7377 in which R~ repre~ent~ a C~,-alkylene radlcal, whlch 1 un~ubstituted or ~ubst~tuted by 1 or 2 C~O-alkyl group~, and X repre~ents oxygen or an imino group, which i~
substituted by C,l~-alkyl, benzyl or phenyl, to give di~stereomerically pure compounds of the general formulae (Va) and ~Vb) Me e COOR' ~ CoOR7 (S)-form (Va) or (R)-form (Vb) in the presence or ab~ence of inert organic salvent~ and the~e are then hydrolysed by conventional methods to give enantiomerically pure ketoprofen.
The invention al~o relateR to the diastereomerically pure esters of the formula (V), in which R' ha~ the meaning given above and to their u~e in the preparation of (R)-or (S)-ketoprofen.
The prepar~tion of the novel dia~tereomerically pure compounds according to the invention of the general Le A 28 573 - 5 -Z~!75~7~;
formula ~VI is preferably carried out ~tarting with the chloride of the acid of the formula (II) in the presence of a tertiary amine, in particular of an alkyl- or cyclo-alkylamine having in each cas~ up to 10 C atom~, in S particular having up to 6 C atoms, of a benzyl- or a phenylamine where the phenyl ring~ are unsubstituted or substituted by halogen, alkyl or alkoxy having up to 5 C
atoms, in a nonpolar solvent at temperatures between -80C and +25C with an optically active alcohol of the formula (IV), in which ~' has the meaning given above.
The hydrolysis of compounds of the general formula (V) to give the enantiomerically pure forms of ketoprofen is preferably carried out under basic conditions. The enantiomeric excess can be increased by conventional crystallisation processes.
Particularly preferred optically active alcohols of the general formula (IV) which can be mentioned are ~-hydroxyesters and u-hydroxyamides such as the isobutyl, ethyl, methyl, isopropyl and benzyl esters of lactic acid, or N,N-dimethyllactamide, and also ~-hydroxylactones or ~-hydroxyimides. The corresponding esters of the general formula (V) are likewise preferred.
Preferred tertiary amines for the reaction of the acid chlorides to give the ketenes are open-chain or cyclic trialkylamines. Particularly preferred amines are tri-(C~ 5)-alkylamine8 such as for axample trimethylamine, dimethylethylamine, triethyl~mine, 1,4-diaza-bicyclo-Le A 28 573 - 6 -Z3:~7 ~7~
t2,2,2]-octane (DABC0) or N-methylpyrrolidine.
The presence of the amine is not critical for the pre~ent process. The tertiary amine is preferably u3ed in a ratio of 0.01 to 10 molar equivalents relative to ketene (III), particularly preferably in a ratio of 0.01 to 2 molar equivalents of amine relative to ketene.
Suitable solvents for the reaction are aprotic liquids which are inert to the reactants. Examples of such solvents are hydrocarbons, such as for example hexane, heptane, toluene or cyclohexane, or ethers such as for example diethyl ether, tetrahydrofuran or tert-butyl methyl ether. Preferred solvents are hexane, heptane and toluene.
In the present process, the ~-hydroxyester or the ~-hydroxyamide is added to a solution of the ketene.
However, with larger batches, it can be a processing advantage to add the ketene (III) in solution to the ~-hydroxyester or ~-hydroxyamide.
The preparation of the ketene proceeds from the acid chlorides with the aid of the bases, in a nonpolar solvent, the solvent used expediently being that which is also used for the reaction of the ketene ~III), at temperatures between -20C and 50C, the ketene being formed immediately in a suitable reaction procedure and isolation being omitted. The amine hydrochlorides formed generally do not interfere in the subsequent reactions.
Le A 28 573 - 7 -2~7.~7~
The molar ratio of ketene ~II) to ~-hydroxye~ter or ~-hydroxyamide ~IV) can be 1 to 1.5, proferably 1 to 1.2.
Particular proference i8 given to the molar ratio of approximately 1:1. The proferred reaction temperature i~
in the range from -20C to -100C, but a temperature from -78C to -60C is particularly preferred. The u~able ketene concentration iB in a range from 1.0 M to 0.01 M.
The reaction mixture i8 stirred at the preferred temperature for 0.5 to 16 hour~. When the reaction is completed the diastereomeric esters are worked up and purified by standard processes and techniques, such as for example chromatography.
The corresponding diastereomeric esters (V) can be cleaved in a conventional manner, for example under acid conditions (see EP 0 179 487 or R. Lattrell et al., Ann.
Chem., 1974, 870) or under basic conditions (D.A. Evans et al., Tetrahedron Lett., 1987, 6141) or preferably under basic conditions in the LiOH/H2O/acetonitrile/
heptane/0C system (R.~. Larsen et al., J. Am. Chem.
Soc., 111, 7650 (1989)) to give the enantiomerically pure carboxylic acid ketoprofen, which is obtained with high enantiomeric excesses.
Examples The enantiomeric analysis was carried out by known methods ~for example according to EP 379 917) by chromatographic separation on chiral stationary phases.
Le A 28 573 - 8 -.
2r~7s776 Comparison Example A
Preparation of ethyl t(2S)-2-(3-benzoyl-phenyl)-pro-pionyl~-(SI-lactate by addition of the ethyl (S~-lactate to the ketene (conventional procedure) To a solution of 440.0 ml (4.02 mol) of N-ethyldimethyl-amine in 1740 ml of anhydrous toluene are added, in the course of 10 minutes, 366.5 g (1.34 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride at room temperature.
After completion of the addition, (R/S)-2-(3-ben~oyl-phenyl)-propionyl chloride could no longer be identified by means of IR spectroscopy. The resulting mixture i8 cooled to -78C, and a solution of 184.0 ml (1.64 mol) of ethyl (S)-lactate in 1740 ml of anhydrous toluene is added dropwise in the course of 30 min, the internal temperature not being allowed to exceed -70C. After completion of the addition, the mixture is stirred for a further 3 hours at -78C and i8 then slowly warmed to room temperature. 17.0 ml of 3-dimethylaminopropylA~;ne are then added, the mixture is stirred for 30 min at room temperature, washed with water, dried using magnesium sulphate and concentrated to dryness. The residue i~
purified by filtration on silica gel (ethyl acetate/
cyclohexane gradient 1/10 1 1/3 v/v). After concen-tration, a lightDyellow oil is obtained.
Yield: 45.49 g (9.6 % of theory) Diastereomer ratio (SS:RS) by GC analysis: 7.8:1 Le A 28 573 - 9 -.
~ . ~ , ..... .
Z0~5~7fi Example 1 Preparation of ethyl t(2S)-2-(3-benzoyl-phenyl)-pro-pionyl]-~S)-la¢tate by addition of the ketene to the ethyl (S)-lactate A solution of 118.8 ml (1.10 mol) of N-ethyl-dimethyl-amine in 200 ml of anhydrous toluene is added dropwise in the course of one hour in a cooled mixing chamber with stirring to 99.0 g (0.363 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride in 200 ml of toluene at room temperature. The suspension thus formed of ketene and amine hydrochloride is slowly added dropwise with stirring to a solution of 49.5 ml (0.44 mol) of ethyl (S)-lactate in 500 ml of anhydrous toluene and 40 ml (0.37 mol) of N-ethyl-dimethylamine, the internal temper-ature not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addition, the mixture is stirred for a further 3 hours at -78C and is then slowly warmed to room temperature. 4.6 ml of 3-dimethylaminopropylamine are then added, the mixture is stirred for 30 min at room temperature, washed with water, dried usinq magnesium sulphate and concentrated to dryness. ~he residue is purified by filtration on silica gel (ethyl acetate/cyclohexane gradient 1/10 1/3 v/v). After concentration, a light-yellow oil is obtained.
Yield: 84.98 g (65.4 ~ of theory) Diastereomer ratio (SS:RS) by GC analysis: 9.8:1 Le A 28 573 - 10 -z~,~7 ~7~;
H-NMR: (CDC13, 200 MHz) (S,S)-diasterooisomer:
- 1.15 (t, J ~ 7 Hz, 3H; -O-CH,-CH3), 1.47 (d, J - 7 Hz, 3H; -CH-CH3), 1.57 (d, J - 7 Hz, 3H; -CH-CH3), 3.87 (q, J ~ 7 Hz, lH; -CH-C~3), 4.10 (q, J - 7 Hz, 2H; -O-CH~-CH3), 5.08 (q, J ~ 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) (R,S)-diastereo~isomer 6 = 1.16 (t, J - 7 Hz, 3H; -O-CH~-CH3), 1.48 (d, J = 7 Hz, 3H; -CH-CH3), 1.58 (d, J s 7 Hz, 3H; -CH-CH3), 3.89 (q~ J s 7 Hz, lH; -CH-CH3), 4.10 (q, J - 7 Hz, 2H; -O-CH2-CH3), 5.08 (q, J s 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) MS: (CI, isobutane) m/e - 355 (M+H), 310 (4 %), 249 (6 %), 236 (6 %), 209 (16 ~), 105 (6 %) Exam~le 2 Preparation of ethyl ~(2S)-2-(3-benzoyl-phenyl)-pro-pionyl]-(S)-lactate by addition of the ketene to the lactate (concentrated reaction procedure) A solution of 591 ml (5.46 mol) of N-ethyl-dimethylamine in 500 ml of anhydrous toluene is added dropwiqe in the course of one hour in a cooled mixing chamber with stirring to 492.47 g (1.81 mol) of (R/S)-2-(3-benzoyl-Le A 28 573 - 11 -z~ j7~
phenyl)-propionyl chloride in 500 ml of toluene at room t~mperature, The suspension thus formed of keteno and amine hydrochloride is ~lowly added dropwise with stirring to a solution of 247 ml ~2.18 mol) of ethyl (S)-lactate in 1000 ml of anhydrou~ toluene and 197 ml (1.82 mol) of N-ethyldimethylamine, the internal temperature not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addi-tion, the mixture is stirred for a further 3 hours at -78C and is then 910wly warmed to room temperature. 4.6 ml of 3-dimethylaminopropylamine are then added, the mixture i~ stirred for 30 min at room temperature, washed with water, dried using magnesium sulphate and concentrated to dryness. The residue is purified by filtration on silica gel (ethyl acetate/cyclohexane gradient 1/10 . 1/3 v/v). After concentration, a light-yellow oil is obtained.
Yield: 436.98 g (68.0 % of theory) Diastereomer ratio (SS:RS) by GC analysis: 9.5:1 Preparation of (2S)-2-(3-benzoyl-phenyl)-propionic acid (ketoprofen) by basic hydrolysis A mixture of 436.98 g (1.234 mol) of ethyl [(2S)-2-(3-benzoyl-phenyl)-propionyl]-(S)-lactate (diastereomer ratio (SS:RS) by GC analysis: 9.5:1) in 237.95 g of lithium hydroxide, 2200 ml of water, 2360 ml of aceto-nitrile and 2360 ml of heptane is processed overnight with intensive stirring using a mechani cal sti rrer . The Le A 28 573 - 12 -2~:~7~7~' acetonitrile~water phase.is then separated and concentrated in vacuo at 25C
to remove the acetonitrile. The residue obtained is taken up in ethyl acetate and extracted with sodium hydroxide ~olution. The basic extract is acidified with hydrochloric acid and is extracted with ethyl acetate, dried and concentrated.
Yield: 300.91 g (1.185 mol) ~96.0 ~ of theory) Enantiomeric excess: 74.9 % (HPLC) ComParison Example B
Preparation of isobutyl ~(2R)-2-(3-benzoyl-phenyl)-propionyl3-(R)-lactate by addition of the isobutyl (R)-lactate to the ketene (conventional procedure) To a solution of 40.0 ml (0.370 mol) of N-ethyldimethyl-amine in 190 ml of anhydrous toluene are added in the course of one hour 49.83 g (0.183 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride at room temperature.
After completion of the addition, (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride could no longer be identified by means of IR spectroscopy. The resulting mixture is cooled to -78C, and a solution of 33.22 ml (0.220 mol) of isobutyl R-lactate in 190 ml of anhydrous toluene is added dropwise in the cour~e of 30 min, the internal temperature not being allowed to exceed -70C. After completion of the addition, the mixture is stirred for a further 3 hours at -78C and is then slowly warmed to room temperature. 2.5 ml of 3-dimethylaminopropylamine are then added, the mixture is stirred for 30 min at room Le A 28 573 - 13 -2~7 j~7~i temperature, washed with water, dried u~ing magnesium sulphate and concentrated to dryne~. The re-idue i~
purified by filtration on ~ilica gel (ethyl acetate/-cyclohexane gradient 1/10 1/3 v/v). After concen-tration, a light-yellow oil iB obtained.
Yield: 22.28 g ~58.10 mmol) ~31.7 ~ of theory) Diastereomer ratio (RR:SR) by GC analysis: 4.0~1 ExamDle 3 Preparation of isobutyl t(2R)-2-~3-benzoyl-phenyl)-propionyl3-(R)-lactate by addition of the ketene to the isobutyl (R)-lactate A solution of 150 ml (1.10 mol) of N-ethyl-dimethyl~m;ne in 240 ml of anhydrou~ toluene i8 added dropwise in the course of one hour in a cooled mixing chamber with stirring to 125.0 g (0.459 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride in 240 ml of toluene at room temperature. The suspension thus formed of ketene and amine hydrochloride is slowly added dropwise with stirring to a solution of 50.0 ml (0.44 mol) of i~obutyl (R)-lactate in 475 ml of anhydrous toluene and 150 ml (0.37 mol) of N-ethyldimethylamine, the internal tempera-ture not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addition, the mixture is stirred for a further 3 hours at -78C and i8 then slowly warmed to room temperature.
4.6 ml of 3-dimethylaminopropylamine are then added, the Le A 28 573 - 14 -2~757~
mixture i~ stirred for 30 min at room temperature, wa~hod with water, driod u~ing magne~ium eulphate and concen-trated to drynoss. The re~idue i~ purified by filtration on ~ilica gel ~ethyl acetato/cyclohexane gradient 1: 10 , 1/3 v/v) . Aftor concentration a light-yellow oil i~ obtained.
Yield: 113.77 g (0.30 mol) (65.4 % of theory) Dia~tereomer ratio (M:SR) by GC analy~ 9.8: 1 IH-NMR: (CDC13, 200 MHz) (S,S)-diastereoisomer:
6 -- 0.85 (d, J -- 7 Hz, 6H; -CH-(CH3)2), 1.49 ( d , J -- 7 Hz , 3H ; -CH-CH3), 1.57 (d, J - 7 Hz, 3H; -CH-CH3), 1.83 (mc, lH; -CH2-CH-(CH3),), 3.85 (d, 2H, J -- 7 Hz; -CH2-CH-), 3.89 (q, J -- 7 Hz, lH; -CH-CH3), 5.11 (q, J = 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H, arom. H) (S,R) -di astereoi somer ~ ~ 0.92 (d, J ~ 7 Hz, 6H; -CH-(CH3)2), 1.46 (d, J -- 7 Hz, 3H; -CH-CH3), 1.54 (d, J - 7 Hz, 3H; -CH-CH3), 1.83 (mc, lH; -CH2-CH-(CH3)2), 3.85 (d, 2H, 7 Hz, -CH2-CH-), 3.89 (g, J -- 7 Hz, lH; -CH-CH3), 5.11 (q, J - 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) Le A 28 573 - 15 -X~ ~ 7~;
MS: (C~, isobutane) m/o - 383 (M+H), (lO0 %, M+H), 3.27 (14 %), 209 (20 %), 105 (8 %) Preparation of (2~)-2 (3-benzoyl-phenyl)-propionic acid (ketoprofen) by ba~ic hydrolysiQ
S A mixture of 113.77 g (0.297 mol) of isobutyl [(2R)-2-(3-benzoyl-phenyl)-propionyl]-(R)-lactate (diastereomer ratio (RR:SR) by GC analysis: 9.8:1) in 57.49 g of lithium hydroxide, 525 ml of water, 570 ml of aceto-nitrile and 570 ml of heptane is processed overnight with intensive stirring using a mechanical stirrer. The acetonitrile/water phase is then separated and concentrated in vacuo at 25C to r~ve the acetonitrile. The resid~
obtained i3 taken up in ethyl acetate and extracted with sodium hydroxide solution. The basic extract is acidified with hydrochloric acid and extracted with ethyl acetate, dried and concentrated.
Yield: 67.14 g (0.264 mol) (89.0 % of theory) Enantiomeric excess: 74.0 % (HPLC) Le A 28 5?3 - 16 -
The invention relateq to novel diastereomerically pure esters of ketoprofen, to processe~ for their preparation by asymmetric ketene addition ~nd to their use in the preparation of (R)- or (S)-ketoprofen.
Pharmacological properties of active ingredients very often depend on the ab~olute stereochemistry. This phenomenon has also been observed with nonsteroidal analgesics and antipyretics of the class of 2-aryl-propionic acids. For these reasons various methods for the preparation of enantiomerically pure carboxylic acids having a chiral ~-C atom have been developed.
The preparation of (S)- or (R)-ketoprofen by methods known to date gives only poor results. In the racemate separation of 2-(3-benzylphenyl)-propionic acid and also in the asymmetric hydrogenation of dehydroketoprofen using chiral rhodium catalysts, only poor yields are obtained, ju~t as i8 the case with oxidation to give (S)-ketoprofen (compare G. Comisso et al., Gazz. Chim.
Italia 110, 123 (1980)). Thi~ also applies to racemate separation of 2-(2-thiaxanthonyl)-propionic acids with subsequent multistage conversion to (S)-ketoprofen (compare US 3 641 127) and to direct racemate separation using phenethylamins (compare DE 3 824 353). Also, by chromatographic separation of the diastereomeric amides of ketoprofen with chiral amines, only small amounts of (S3-ketoprofen are obtainable following hydrolysis of the Le A 28 573 - 1 -Z~7;~776 amides (compare Abas et al., J. Pharmacol. Exp. Ther.
240, 637 ~1987)). Enzymatic e~tor hydroly~e~ also fail in the preparation of enantiomerically puro ketoprofon ~compare S.~. Wu ot al., J. Am. Chom. Soc., 112, 1990 (1990)).
In summary it can be ~aid that no suitable prep~ration processe~ are known to date for the industrial production of relatively large amounts of (S)- or (R)-ketoprofen.
It is further known to react activated racemic carboxylic acid derivatives with catalysis using chiral titanium complexes to give enantiomerically enriched esters (compare X. Narasaka et al., Chem. Lett. 1989, 1187).
These reactions have the advantage over classical racemate separation that they can in principle deliver yields greater than 50 %. US 4 691 020 and EP 390 273 further disclose additions of optically active alcohols ; and ~-hydroxyesters or ~-hydroxyamides ta certain ketenes, which lead to esters having diastereomeric ~; excesses.
' It is shown that the hitherto known and conventional methods for the separation of optical isomers of 2-aryl-propionic acids cannot be directly applied to ketoprofen.
`- Methods which can be used successfully, for example with the arylpropionic acid ibuprofen, fail when they are applied to ketoprofen or give only unsatisfactory yields.
In a comparison of the structures, those skilled in the art could infer that, in the ca~e of ketoprofen, Le A 28 573 - 2 -2 ~ S~7 ~
particularly difficult ~teric conditions are prosent.
It has surprisingly been fount that ~S)- and ~R)-keto-profen of the formulae Ia and Ib, respectively, ~ ~Y
o ~ OOH O
~ (St ~ ~ R) Ia Ib (S-ketoprofen) (R-ketoprofen) are obtained in a simple manner, in high purity and in good yields, if racemic ketoprofen of the formula Me COOH
~ (II) i9 reacted via the acid chloride in the preRence of tertiary amines to give ketenes of the general formula (III) : Me C=C=o ~ (III) Le A 28 573 - 3 -2~ 7fi this ketene is then transferred into a eeparate reaction vessel and i8 there reacted at temperatures between -100C and +25C with alcohols of the general formula (IV) Rl-OH (IV) in which IR~
Rl represents the -CH-CO-Y radical, where R~ represents a C~lO-alkyl radical, C3,-cycloalkyl 10radical, ben~yl or phenyl, and Y rapresents a C,10-alkoxy radical, a C3l0-cyclo-alkyloxy radical, benzyloxy or phenoxy, or Y represents an amine radical, which iB identi-cally or differently substituted by alkyl or cycloalkyl having up to 10 C atoms, benzyl or phenyl, or Rl represents a radical of the formula ~3 - x -CH - CO
Le A 28 573 - 4 -z ~7 Sq7 6 23189-7377 in which R~ repre~ent~ a C~,-alkylene radlcal, whlch 1 un~ubstituted or ~ubst~tuted by 1 or 2 C~O-alkyl group~, and X repre~ents oxygen or an imino group, which i~
substituted by C,l~-alkyl, benzyl or phenyl, to give di~stereomerically pure compounds of the general formulae (Va) and ~Vb) Me e COOR' ~ CoOR7 (S)-form (Va) or (R)-form (Vb) in the presence or ab~ence of inert organic salvent~ and the~e are then hydrolysed by conventional methods to give enantiomerically pure ketoprofen.
The invention al~o relateR to the diastereomerically pure esters of the formula (V), in which R' ha~ the meaning given above and to their u~e in the preparation of (R)-or (S)-ketoprofen.
The prepar~tion of the novel dia~tereomerically pure compounds according to the invention of the general Le A 28 573 - 5 -Z~!75~7~;
formula ~VI is preferably carried out ~tarting with the chloride of the acid of the formula (II) in the presence of a tertiary amine, in particular of an alkyl- or cyclo-alkylamine having in each cas~ up to 10 C atom~, in S particular having up to 6 C atoms, of a benzyl- or a phenylamine where the phenyl ring~ are unsubstituted or substituted by halogen, alkyl or alkoxy having up to 5 C
atoms, in a nonpolar solvent at temperatures between -80C and +25C with an optically active alcohol of the formula (IV), in which ~' has the meaning given above.
The hydrolysis of compounds of the general formula (V) to give the enantiomerically pure forms of ketoprofen is preferably carried out under basic conditions. The enantiomeric excess can be increased by conventional crystallisation processes.
Particularly preferred optically active alcohols of the general formula (IV) which can be mentioned are ~-hydroxyesters and u-hydroxyamides such as the isobutyl, ethyl, methyl, isopropyl and benzyl esters of lactic acid, or N,N-dimethyllactamide, and also ~-hydroxylactones or ~-hydroxyimides. The corresponding esters of the general formula (V) are likewise preferred.
Preferred tertiary amines for the reaction of the acid chlorides to give the ketenes are open-chain or cyclic trialkylamines. Particularly preferred amines are tri-(C~ 5)-alkylamine8 such as for axample trimethylamine, dimethylethylamine, triethyl~mine, 1,4-diaza-bicyclo-Le A 28 573 - 6 -Z3:~7 ~7~
t2,2,2]-octane (DABC0) or N-methylpyrrolidine.
The presence of the amine is not critical for the pre~ent process. The tertiary amine is preferably u3ed in a ratio of 0.01 to 10 molar equivalents relative to ketene (III), particularly preferably in a ratio of 0.01 to 2 molar equivalents of amine relative to ketene.
Suitable solvents for the reaction are aprotic liquids which are inert to the reactants. Examples of such solvents are hydrocarbons, such as for example hexane, heptane, toluene or cyclohexane, or ethers such as for example diethyl ether, tetrahydrofuran or tert-butyl methyl ether. Preferred solvents are hexane, heptane and toluene.
In the present process, the ~-hydroxyester or the ~-hydroxyamide is added to a solution of the ketene.
However, with larger batches, it can be a processing advantage to add the ketene (III) in solution to the ~-hydroxyester or ~-hydroxyamide.
The preparation of the ketene proceeds from the acid chlorides with the aid of the bases, in a nonpolar solvent, the solvent used expediently being that which is also used for the reaction of the ketene ~III), at temperatures between -20C and 50C, the ketene being formed immediately in a suitable reaction procedure and isolation being omitted. The amine hydrochlorides formed generally do not interfere in the subsequent reactions.
Le A 28 573 - 7 -2~7.~7~
The molar ratio of ketene ~II) to ~-hydroxye~ter or ~-hydroxyamide ~IV) can be 1 to 1.5, proferably 1 to 1.2.
Particular proference i8 given to the molar ratio of approximately 1:1. The proferred reaction temperature i~
in the range from -20C to -100C, but a temperature from -78C to -60C is particularly preferred. The u~able ketene concentration iB in a range from 1.0 M to 0.01 M.
The reaction mixture i8 stirred at the preferred temperature for 0.5 to 16 hour~. When the reaction is completed the diastereomeric esters are worked up and purified by standard processes and techniques, such as for example chromatography.
The corresponding diastereomeric esters (V) can be cleaved in a conventional manner, for example under acid conditions (see EP 0 179 487 or R. Lattrell et al., Ann.
Chem., 1974, 870) or under basic conditions (D.A. Evans et al., Tetrahedron Lett., 1987, 6141) or preferably under basic conditions in the LiOH/H2O/acetonitrile/
heptane/0C system (R.~. Larsen et al., J. Am. Chem.
Soc., 111, 7650 (1989)) to give the enantiomerically pure carboxylic acid ketoprofen, which is obtained with high enantiomeric excesses.
Examples The enantiomeric analysis was carried out by known methods ~for example according to EP 379 917) by chromatographic separation on chiral stationary phases.
Le A 28 573 - 8 -.
2r~7s776 Comparison Example A
Preparation of ethyl t(2S)-2-(3-benzoyl-phenyl)-pro-pionyl~-(SI-lactate by addition of the ethyl (S~-lactate to the ketene (conventional procedure) To a solution of 440.0 ml (4.02 mol) of N-ethyldimethyl-amine in 1740 ml of anhydrous toluene are added, in the course of 10 minutes, 366.5 g (1.34 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride at room temperature.
After completion of the addition, (R/S)-2-(3-ben~oyl-phenyl)-propionyl chloride could no longer be identified by means of IR spectroscopy. The resulting mixture i8 cooled to -78C, and a solution of 184.0 ml (1.64 mol) of ethyl (S)-lactate in 1740 ml of anhydrous toluene is added dropwise in the course of 30 min, the internal temperature not being allowed to exceed -70C. After completion of the addition, the mixture is stirred for a further 3 hours at -78C and i8 then slowly warmed to room temperature. 17.0 ml of 3-dimethylaminopropylA~;ne are then added, the mixture is stirred for 30 min at room temperature, washed with water, dried using magnesium sulphate and concentrated to dryness. The residue i~
purified by filtration on silica gel (ethyl acetate/
cyclohexane gradient 1/10 1 1/3 v/v). After concen-tration, a lightDyellow oil is obtained.
Yield: 45.49 g (9.6 % of theory) Diastereomer ratio (SS:RS) by GC analysis: 7.8:1 Le A 28 573 - 9 -.
~ . ~ , ..... .
Z0~5~7fi Example 1 Preparation of ethyl t(2S)-2-(3-benzoyl-phenyl)-pro-pionyl]-~S)-la¢tate by addition of the ketene to the ethyl (S)-lactate A solution of 118.8 ml (1.10 mol) of N-ethyl-dimethyl-amine in 200 ml of anhydrous toluene is added dropwise in the course of one hour in a cooled mixing chamber with stirring to 99.0 g (0.363 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride in 200 ml of toluene at room temperature. The suspension thus formed of ketene and amine hydrochloride is slowly added dropwise with stirring to a solution of 49.5 ml (0.44 mol) of ethyl (S)-lactate in 500 ml of anhydrous toluene and 40 ml (0.37 mol) of N-ethyl-dimethylamine, the internal temper-ature not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addition, the mixture is stirred for a further 3 hours at -78C and is then slowly warmed to room temperature. 4.6 ml of 3-dimethylaminopropylamine are then added, the mixture is stirred for 30 min at room temperature, washed with water, dried usinq magnesium sulphate and concentrated to dryness. ~he residue is purified by filtration on silica gel (ethyl acetate/cyclohexane gradient 1/10 1/3 v/v). After concentration, a light-yellow oil is obtained.
Yield: 84.98 g (65.4 ~ of theory) Diastereomer ratio (SS:RS) by GC analysis: 9.8:1 Le A 28 573 - 10 -z~,~7 ~7~;
H-NMR: (CDC13, 200 MHz) (S,S)-diasterooisomer:
- 1.15 (t, J ~ 7 Hz, 3H; -O-CH,-CH3), 1.47 (d, J - 7 Hz, 3H; -CH-CH3), 1.57 (d, J - 7 Hz, 3H; -CH-CH3), 3.87 (q, J ~ 7 Hz, lH; -CH-C~3), 4.10 (q, J - 7 Hz, 2H; -O-CH~-CH3), 5.08 (q, J ~ 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) (R,S)-diastereo~isomer 6 = 1.16 (t, J - 7 Hz, 3H; -O-CH~-CH3), 1.48 (d, J = 7 Hz, 3H; -CH-CH3), 1.58 (d, J s 7 Hz, 3H; -CH-CH3), 3.89 (q~ J s 7 Hz, lH; -CH-CH3), 4.10 (q, J - 7 Hz, 2H; -O-CH2-CH3), 5.08 (q, J s 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) MS: (CI, isobutane) m/e - 355 (M+H), 310 (4 %), 249 (6 %), 236 (6 %), 209 (16 ~), 105 (6 %) Exam~le 2 Preparation of ethyl ~(2S)-2-(3-benzoyl-phenyl)-pro-pionyl]-(S)-lactate by addition of the ketene to the lactate (concentrated reaction procedure) A solution of 591 ml (5.46 mol) of N-ethyl-dimethylamine in 500 ml of anhydrous toluene is added dropwiqe in the course of one hour in a cooled mixing chamber with stirring to 492.47 g (1.81 mol) of (R/S)-2-(3-benzoyl-Le A 28 573 - 11 -z~ j7~
phenyl)-propionyl chloride in 500 ml of toluene at room t~mperature, The suspension thus formed of keteno and amine hydrochloride is ~lowly added dropwise with stirring to a solution of 247 ml ~2.18 mol) of ethyl (S)-lactate in 1000 ml of anhydrou~ toluene and 197 ml (1.82 mol) of N-ethyldimethylamine, the internal temperature not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addi-tion, the mixture is stirred for a further 3 hours at -78C and is then 910wly warmed to room temperature. 4.6 ml of 3-dimethylaminopropylamine are then added, the mixture i~ stirred for 30 min at room temperature, washed with water, dried using magnesium sulphate and concentrated to dryness. The residue is purified by filtration on silica gel (ethyl acetate/cyclohexane gradient 1/10 . 1/3 v/v). After concentration, a light-yellow oil is obtained.
Yield: 436.98 g (68.0 % of theory) Diastereomer ratio (SS:RS) by GC analysis: 9.5:1 Preparation of (2S)-2-(3-benzoyl-phenyl)-propionic acid (ketoprofen) by basic hydrolysis A mixture of 436.98 g (1.234 mol) of ethyl [(2S)-2-(3-benzoyl-phenyl)-propionyl]-(S)-lactate (diastereomer ratio (SS:RS) by GC analysis: 9.5:1) in 237.95 g of lithium hydroxide, 2200 ml of water, 2360 ml of aceto-nitrile and 2360 ml of heptane is processed overnight with intensive stirring using a mechani cal sti rrer . The Le A 28 573 - 12 -2~:~7~7~' acetonitrile~water phase.is then separated and concentrated in vacuo at 25C
to remove the acetonitrile. The residue obtained is taken up in ethyl acetate and extracted with sodium hydroxide ~olution. The basic extract is acidified with hydrochloric acid and is extracted with ethyl acetate, dried and concentrated.
Yield: 300.91 g (1.185 mol) ~96.0 ~ of theory) Enantiomeric excess: 74.9 % (HPLC) ComParison Example B
Preparation of isobutyl ~(2R)-2-(3-benzoyl-phenyl)-propionyl3-(R)-lactate by addition of the isobutyl (R)-lactate to the ketene (conventional procedure) To a solution of 40.0 ml (0.370 mol) of N-ethyldimethyl-amine in 190 ml of anhydrous toluene are added in the course of one hour 49.83 g (0.183 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride at room temperature.
After completion of the addition, (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride could no longer be identified by means of IR spectroscopy. The resulting mixture is cooled to -78C, and a solution of 33.22 ml (0.220 mol) of isobutyl R-lactate in 190 ml of anhydrous toluene is added dropwise in the cour~e of 30 min, the internal temperature not being allowed to exceed -70C. After completion of the addition, the mixture is stirred for a further 3 hours at -78C and is then slowly warmed to room temperature. 2.5 ml of 3-dimethylaminopropylamine are then added, the mixture is stirred for 30 min at room Le A 28 573 - 13 -2~7 j~7~i temperature, washed with water, dried u~ing magnesium sulphate and concentrated to dryne~. The re-idue i~
purified by filtration on ~ilica gel (ethyl acetate/-cyclohexane gradient 1/10 1/3 v/v). After concen-tration, a light-yellow oil iB obtained.
Yield: 22.28 g ~58.10 mmol) ~31.7 ~ of theory) Diastereomer ratio (RR:SR) by GC analysis: 4.0~1 ExamDle 3 Preparation of isobutyl t(2R)-2-~3-benzoyl-phenyl)-propionyl3-(R)-lactate by addition of the ketene to the isobutyl (R)-lactate A solution of 150 ml (1.10 mol) of N-ethyl-dimethyl~m;ne in 240 ml of anhydrou~ toluene i8 added dropwise in the course of one hour in a cooled mixing chamber with stirring to 125.0 g (0.459 mol) of (R/S)-2-(3-benzoyl-phenyl)-propionyl chloride in 240 ml of toluene at room temperature. The suspension thus formed of ketene and amine hydrochloride is slowly added dropwise with stirring to a solution of 50.0 ml (0.44 mol) of i~obutyl (R)-lactate in 475 ml of anhydrous toluene and 150 ml (0.37 mol) of N-ethyldimethylamine, the internal tempera-ture not being allowed to exceed -70C (controllable by the rate of ketene addition). After completion of the addition, the mixture is stirred for a further 3 hours at -78C and i8 then slowly warmed to room temperature.
4.6 ml of 3-dimethylaminopropylamine are then added, the Le A 28 573 - 14 -2~757~
mixture i~ stirred for 30 min at room temperature, wa~hod with water, driod u~ing magne~ium eulphate and concen-trated to drynoss. The re~idue i~ purified by filtration on ~ilica gel ~ethyl acetato/cyclohexane gradient 1: 10 , 1/3 v/v) . Aftor concentration a light-yellow oil i~ obtained.
Yield: 113.77 g (0.30 mol) (65.4 % of theory) Dia~tereomer ratio (M:SR) by GC analy~ 9.8: 1 IH-NMR: (CDC13, 200 MHz) (S,S)-diastereoisomer:
6 -- 0.85 (d, J -- 7 Hz, 6H; -CH-(CH3)2), 1.49 ( d , J -- 7 Hz , 3H ; -CH-CH3), 1.57 (d, J - 7 Hz, 3H; -CH-CH3), 1.83 (mc, lH; -CH2-CH-(CH3),), 3.85 (d, 2H, J -- 7 Hz; -CH2-CH-), 3.89 (q, J -- 7 Hz, lH; -CH-CH3), 5.11 (q, J = 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H, arom. H) (S,R) -di astereoi somer ~ ~ 0.92 (d, J ~ 7 Hz, 6H; -CH-(CH3)2), 1.46 (d, J -- 7 Hz, 3H; -CH-CH3), 1.54 (d, J - 7 Hz, 3H; -CH-CH3), 1.83 (mc, lH; -CH2-CH-(CH3)2), 3.85 (d, 2H, 7 Hz, -CH2-CH-), 3.89 (g, J -- 7 Hz, lH; -CH-CH3), 5.11 (q, J - 7 Hz, lH; -CH-CH3), 7.40 - 7.90 (m, 9H; arom. H) Le A 28 573 - 15 -X~ ~ 7~;
MS: (C~, isobutane) m/o - 383 (M+H), (lO0 %, M+H), 3.27 (14 %), 209 (20 %), 105 (8 %) Preparation of (2~)-2 (3-benzoyl-phenyl)-propionic acid (ketoprofen) by ba~ic hydrolysiQ
S A mixture of 113.77 g (0.297 mol) of isobutyl [(2R)-2-(3-benzoyl-phenyl)-propionyl]-(R)-lactate (diastereomer ratio (RR:SR) by GC analysis: 9.8:1) in 57.49 g of lithium hydroxide, 525 ml of water, 570 ml of aceto-nitrile and 570 ml of heptane is processed overnight with intensive stirring using a mechanical stirrer. The acetonitrile/water phase is then separated and concentrated in vacuo at 25C to r~ve the acetonitrile. The resid~
obtained i3 taken up in ethyl acetate and extracted with sodium hydroxide solution. The basic extract is acidified with hydrochloric acid and extracted with ethyl acetate, dried and concentrated.
Yield: 67.14 g (0.264 mol) (89.0 % of theory) Enantiomeric excess: 74.0 % (HPLC) Le A 28 5?3 - 16 -
Claims (8)
1. Diastereomerically pure compounds of the general formulae (Va) and (Vb) (S)-form (Va) or (R)-form (Vb) in which R1 represents the radical, where R2 represents a C1-10-alkyl radical, C3-5-cycloalkyl radical, benzyl or phenyl, and Y represents a C1-10-alkoxy radical, a C3-10-cycloalkyloxy radical, benzyloxy or phenoxy, or Y represents an amine radical, which is identically or differently substituted by alkyl or cycloalkyl having up to 10 C
Le A 28 573 - 17 -atoms, benzyl or phenyl, or R1 represents a radical of the formula in which R3 represents a C2-4-alkylene radical, which is unsubstituted or substituted by 1 or 2 C1-10alkyl groups, and X represents oxygen or an imino group, which is substituted by C1-10-alkyl, benzyl or phenyl.
Le A 28 573 - 17 -atoms, benzyl or phenyl, or R1 represents a radical of the formula in which R3 represents a C2-4-alkylene radical, which is unsubstituted or substituted by 1 or 2 C1-10alkyl groups, and X represents oxygen or an imino group, which is substituted by C1-10-alkyl, benzyl or phenyl.
2. Process for the preparation of compounds of the general formula (V) according to Claim 1, charac-terised in that racemic ketoprofen of the formula (II) (II) is reacted via the acid chloride in the presence of a tertiary amine to give a ketene of the general Le A 28 573 - 18 -formula (III) (III) this ketene is then transferred into a separate reaction vessel and is there reacted at temperatures between -100°C and +25°C with an alcohol of the general formula (IV) R1-OH (IV) in which R1 has the meaning given in Claim 1, to give diastereomerically pure compounds of the general formulae (Va) and (Vb) (S)-form (Va) or (R)-form (Vb) in the presence or absence of inert organic solvents.
3. Use of compounds of the general formula (V) accord-ing to Claim 1 for the preparation of (R)- or (S)-ketoprofen.
4. Process for the preparation of (R)- and (S)-keto-profen, characterised in that diasteromerically pure esters of the general formula (V) according to Claim 1 are hydrolysed by conventional methods.
Le A 28 573 - 19 -
Le A 28 573 - 19 -
5. Process according to Claim 4, characterised in that the hydrolysis is carried out under basic conditions.
6. Process according to Claim 2, wherein the alcohol of the formula R1-OH (IV) is an alpha-hydroxylactone or alpha-hydroxyimide of the formula:
(wherein R3 represents a C2-4 alkylene radical which is un-substituted or substituted by one or two C1-10 alkyl groups, and X represents oxygen or an imino group which is substituted by C1-10 alkyl, benzyl or phenyl).
(wherein R3 represents a C2-4 alkylene radical which is un-substituted or substituted by one or two C1-10 alkyl groups, and X represents oxygen or an imino group which is substituted by C1-10 alkyl, benzyl or phenyl).
7. The process according to Claim 2, wherein the alcohol of the formula R1-OH (IV) is a lactate.
8. The compound according to Claim 1, wherein R2 is ethyl and Y is C1-10 alkoxy, C3-10 cycloalkoxy, benzyloxy or phenoxy.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4126859A DE4126859A1 (en) | 1991-08-14 | 1991-08-14 | DIASTEREOMERIC INTERMEDIATE PRODUCTS AND THEIR USE IN THE PRODUCTION OF (R) - OR (S) -KETOPROFENS |
DEP4126859.8 | 1991-08-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2075776A1 true CA2075776A1 (en) | 1993-02-15 |
Family
ID=6438275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002075776A Abandoned CA2075776A1 (en) | 1991-08-14 | 1992-08-11 | Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofen |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0531700A3 (en) |
JP (1) | JPH05262697A (en) |
KR (1) | KR930004244A (en) |
CA (1) | CA2075776A1 (en) |
DE (1) | DE4126859A1 (en) |
FI (1) | FI923617A (en) |
HU (1) | HUT62252A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5808069A (en) * | 1993-03-09 | 1998-09-15 | Dompe' Farmaceutici Spa | Salts of 2-(3-benzoylphenyl) propionic acid with organic bases and pharmaceutical compositions thereof |
WO2003089448A1 (en) * | 2002-04-22 | 2003-10-30 | Hualu Wang | Ibuprofen ribavirin ester, its method of preparation and use |
JP4830435B2 (en) * | 2005-09-30 | 2011-12-07 | 大日本印刷株式会社 | Photosensitive resin composition and article |
JP5152350B2 (en) * | 2011-01-17 | 2013-02-27 | 大日本印刷株式会社 | Photosensitive resin composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940813A (en) * | 1989-03-31 | 1990-07-10 | Merck & Co., Inc. | Resolution of a carboxylic acid |
-
1991
- 1991-08-14 DE DE4126859A patent/DE4126859A1/en not_active Withdrawn
-
1992
- 1992-08-03 EP EP19920113174 patent/EP0531700A3/en not_active Withdrawn
- 1992-08-11 CA CA002075776A patent/CA2075776A1/en not_active Abandoned
- 1992-08-12 FI FI923617A patent/FI923617A/en unknown
- 1992-08-12 JP JP4235156A patent/JPH05262697A/en active Pending
- 1992-08-13 HU HU9202628A patent/HUT62252A/en unknown
- 1992-08-13 KR KR1019920014548A patent/KR930004244A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HU9202628D0 (en) | 1992-10-28 |
HUT62252A (en) | 1993-04-28 |
EP0531700A2 (en) | 1993-03-17 |
DE4126859A1 (en) | 1993-02-18 |
KR930004244A (en) | 1993-03-22 |
EP0531700A3 (en) | 1993-04-14 |
FI923617A0 (en) | 1992-08-12 |
FI923617A (en) | 1993-02-15 |
JPH05262697A (en) | 1993-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3171931B2 (en) | (R)-(-)-4-cyano-3-hydroxybutyric acid t-butyl ester and method for producing the same | |
KR100758620B1 (en) | 4-Alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof | |
US6552204B1 (en) | Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one | |
CA2075776A1 (en) | Diastereomerically pure intermediates and their use in the preparation of (r)- or (s)-ketoprofen | |
KR20040084915A (en) | Novel boronate esters | |
US6403804B1 (en) | Process for preparing optically active oxazolidinone derivative | |
JP5094392B2 (en) | Process for producing optically active 2-hydroxybutyric acid ester | |
JP5094397B2 (en) | Method for producing optically active ester | |
JP4043810B2 (en) | Process for producing optically active 3-chlorocarboxylic acid ester | |
JP3766463B2 (en) | Process for producing enantiomers of 2- (2-fluoro-4-biphenyl) propionic acid | |
JP2691363B2 (en) | Process for producing optically active 3,4-dihydroxybutyric acid derivative | |
JP5329462B2 (en) | Optically active dicarboxylic acid derivative | |
US6667422B2 (en) | Process for the preparation of α-haloketones | |
JP5796762B2 (en) | Method for producing optically active cyclohexene derivative | |
WO2021161101A1 (en) | Preparation of s-beflubutamid by resolving 2-(4-fluoro-3-(trifluoromethyl)phenoxy)butanoic acid | |
JP3879141B2 (en) | Cyclic ester compound and method for producing the same | |
JPH04295469A (en) | Method of manufacturing optically active ester of quinoxalinyloxyphenoxypropionic acid | |
JP4958513B2 (en) | Method for producing sedanenolide | |
JPH1045721A (en) | Production of 1-substituted-4,5-diphenyl-2-imidazolidinone and intermediate for the same | |
JP2002226472A (en) | Amino- and hydroxyfuranone containing one enantiomer richly | |
JPH10509174A (en) | Efficient process for producing N-substituted dehydroamino acid esters | |
JPH09176130A (en) | Optically active 4,5-diphenyl-2-imidazolidinone derivative | |
JP2004067577A (en) | Method for producing thienyl ketoester | |
JPH09208514A (en) | Production of optically active carboxylic acids | |
JPH10101640A (en) | New thioester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |